Skip to main content

Many Bright Ideas Technologies Inc(MBI-H-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.020
Day High0.025
Open:0.025
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

Top Stories: Many Bright Ideas Technologies Inc

Select a category then submit the form to load news
AI-generated - The Globe and Mail
Many Bright Ideas: Top 10 Undervalued Medical Diagnostics & Research Industry Stocks (MBI-H)
The Globe and Mail
Many Bright Ideas: Top 10 Undervalued Medical Diagnostics & Research Industry Stocks (MBI-H)
The Globe and Mail
Many Bright Ideas: Bottom 25 Performing Stocks Year-to-Date on TSX-V (MBI-H)
The Globe and Mail
Many Bright Ideas: Bottom 25 Performing Stocks Year-to-Date on TSX-V (MBI-H)
The Globe and Mail
Many Bright Ideas: Top 10 Undervalued Medical Diagnostics & Research Industry Stocks (MBI-H)
The Globe and Mail
Many Bright Ideas: Top 10 Undervalued Medical Diagnostics & Research Industry Stocks (MBI-H)
The Globe and Mail
Many Bright Ideas: Top 10 Undervalued Medical Diagnostics & Research Industry Stocks (MBI-H)
The Globe and Mail
Many Bright Ideas: Top 25 Undervalued TSX Venture Exchange Stocks (MBI-H)

Profile

Many Bright Ideas Technologies Inc is a Canada-based life science company. It focused on the development and commercialization of genomic-based clinical laboratory diagnostic tests. The company is engaged in managing the license and rights to GeneFx Lung, which is a proprietary gene expression-based test for identifying those patients with early-stage non-small-cell lung cancer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.